|
Market Closed -
Euronext Paris
19:55:00 06/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7010 EUR | -2.50% |
|
+0.14% | +16.45% |
| 11-06 | Theraclion's Ultrasound Platform Sonovein Wins De Novo Marketing Approval in US | MT |
| 11-05 | Theraclion authorized to market its varicose vein treatment in the United States |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| THERACLION | Other Advanced Medical Equipment & Technology | -2.50% | +0.14% | +16.45% | +4.63% | -53.58% | 57.14M |  |  | |
- Stock Market
- Stocks
- ALTHE Stock
- Charts Theraclion
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
